Pentwater Capital Management LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$24,730,241
+6.1%
46,411,0000.0%0.13%
-17.4%
Q2 2023$23,308,486
+24.3%
46,411,0000.0%0.16%
-11.0%
Q1 2023$18,751,436
-25.9%
46,411,0000.0%0.18%
-59.2%
Q4 2022$25,320,496
-3.1%
46,411,0000.0%0.44%
+52.1%
Q3 2022$26,134,000
+3.5%
46,411,0000.0%0.29%
-1.7%
Q2 2022$25,262,000
+4.3%
46,411,0000.0%0.30%
+2.4%
Q1 2022$24,217,000
-2.2%
46,411,0000.0%0.29%
+7.8%
Q4 2021$24,770,00046,411,0000.27%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders